Sian Bigora - 05 Apr 2024 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Development Officer
Signature
/s/ Sian Bigora by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Apr 2024
Net transactions value
-$1,411
Form type
4
Filing time
02 Aug 2024, 17:34:41 UTC
Previous filing
12 Apr 2024
Next filing
11 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1,675 +8.3% 21,827 05 Apr 2024 Direct F1
transaction PCSA Common Stock Tax liability $1,027 -368 -1.7% $2.79 21,459 05 Apr 2024 Direct
transaction PCSA Common Stock Options Exercise +644 +3% 22,103 10 Jul 2024 Direct F1
transaction PCSA Common Stock Tax liability $385 -225 -1% $1.71 21,878 10 Jul 2024 Direct
holding PCSA Common Stock 6,668 05 Apr 2024 By CorLyst, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +3,233 +15% $0.000000 24,728 28 Jun 2024 Common Stock 3,233 $0.000000 Direct F2
transaction PCSA Restricted Stock Units Award $0 +2,425 +9.8% $0.000000 27,153 28 Jun 2024 Common Stock 2,425 $0.000000 Direct F3
transaction PCSA Restricted Stock Units Award $0 +404 +1.5% $0.000000 27,557 28 Jun 2024 Common Stock 404 $0.000000 Direct F4
transaction PCSA Restricted Stock Units Award $0 +404 +1.5% $0.000000 27,961 28 Jun 2024 Common Stock 404 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.